Thalassemia: all 422 studies
Page 4 of 5. Open to participants first (69), then studies with results posted, then the rest; newest registration first within each.
- Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia MajorCompletedNCT02342145Phase 4
- Reproductive Capacity and Iron Burden in ThalassemiaCompletedNCT02308904Not applicable
- Long Term Outcomes in β Thalassemia MajorCompletedNCT02307786
- Safety and Pharmacokinetic Study of Escalating Doses of SP-420, an Iron Chelator, in Patients With β-ThalassemiaTerminatedNCT02274233Phase 1
- Hepcidin Levels in Sickle Cell Disease (SCD)CompletedNCT02258997
- QST-Pupillometry in Sickle Cell Disease PatientsCompletedNCT02242058
- Clinical Trial of Deferasirox Combination Treatment With Deferiprone In Thalassaemia PatientsCompletedNCT02198508Not applicable
- Hematopoietic Stem Cell Transplant for High Risk HemoglobinopathiesTerminatedNCT02179359Not applicable
- An Algorithm to Start Iron Chelation in Minimally Transfused Young Beta-thalassemia Major PatientsStatus unknownNCT02173951Phase 2/3
- Haploidentical Hematopoietic Stem Cell TransplantationCompletedNCT02165007Phase 1
- Use of Mobile Technology for Intensive Training in Medication ManagementCompletedNCT02133560Not applicable
- Unrelated Umbilical Cord Blood Following HLA-haploidentical Hematopoietic Stem Cell Transplantation in Patients With β-thalassemia MajorStatus unknownNCT02126046Not applicable
- MR Imaging of Diffuse Myocardial Fibrosis in Transfusion-Dependent AnemiasCompletedNCT02090699
- Role of Vitamin C to Augment Iron Chelation With DFP or DFXStatus unknownNCT02083575Phase 2/3
- Effect of Deferasirox on Endocrine Complications in Subjects With Transfusion Dependent ThalassemiaWithdrawnNCT02069886Phase 4
- Amlodipine for Myocardial Iron in ThalassemiaCompletedNCT02065492Phase 2/3
- Allograft for Sickle Cell Disease and ThalassemiaWithdrawnNCT02038478Phase 2
- Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)Status unknownNCT01996683Not applicable
- Deferasirox BID (Twice a Day) in Transfusion Dependent Thalassemia Patients With Inadequate Response to High DosesWithdrawnNCT01948817Phase 2
- A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.Status unknownNCT01935661
- At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic ConditionsCompletedNCT01931644
- Treatment of Iron Overload Requiring Chelation TherapyWithdrawnNCT01927913Phase 2
- Bone Marrow Transplant With Abatacept for Non-Malignant DiseasesCompletedNCT01917708Phase 1
- Multi-Center Study of Iron Overload: Survey Study (MCSIO)CompletedNCT01913548
- Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused PopulationsCompletedNCT01911871
- Sickle Cell Anemia - A Comparative Study Between Three Ethnical Communities, a Multicenter StudyStatus unknownNCT01905787
- Renal Function Among Thalassemia Patients Treated by a Oral Chelator DeferasiroxCompletedNCT01905774
- Effect of Metoprolol on Thalassemia CardiomyopathyCompletedNCT01863173Phase 2/3
- B Memory Cell Response to Vaccination With the 13-valent Pneumococcal Conjugate Vaccine in Asplenic IndividualsStatus unknownNCT01846923Phase 4
- Zinc and Diabetes in Patients With Thalassemia: a Pilot StudyCompletedNCT01772680Not applicable
- Bone Marrow and Kidney Transplant for Patients With Chronic Kidney Disease and Blood DisordersCompletedNCT01758042Not applicable
- Study to Evaluate Efficacy and Safety of S303 Treated Red Blood Cells (RBCs)in Subjects With Thalassemia Major Requiring Chronic RBC TransfusionCompletedNCT01740531Phase 3
- An Open Label Study to Evaluate the Pharmacokinetics, Safety, Tolerability and Efficacy of Deferasirox Administered to Chinese Patients With β-thalassemia Major Aged From 2 to Less Than 6 Years OldWithdrawnNCT01724138Phase 4
- Trial of HQK-1001 in Beta Thalassemia Intermedia in LebanonCompletedNCT01642758Phase 2
- Therapeutic Effect and Safety of Combined Hydroxyurea With Recombinant Human Erythropoietin.Status unknownNCT01624038Phase 2/3
- Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in ThailandCompletedNCT01609595Phase 2
- Effect of Antioxidant Cocktail in Beta-thalassemia/Hb E PatientsCompletedNCT01597765Not applicable
- Study of Effects of YisuiShengxueGranules on ThalassemiaCompletedNCT01549080
- Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron OverloadStatus unknownNCT01511848Phase 2/3
- Prevalence of Pulmonary Hypertension (PAH) in Patients With ThalassemiaCompletedNCT01496963
- Demographic, Clinical, Laboratory and Genetical Characteristics of Patients With Beta Thalassemia IntermediaCompletedNCT01443312
- Phase I/II Pilot Study of Mixed Chimerism to Treat HemoglobinopathiesWithdrawnNCT01419704Phase 1/2
- Amlodipine in the Prevention and Treatment of Iron Overload in Patients With Thalassemia MajorCompletedNCT01395199Phase 3
- Efficacy and Safety of Desferal Versus Osveral in Transfusional Iron OverloadCompletedNCT01369719Not applicable
- The Effect of Vitamin D Supplementation on Calcium Excretion in Thalassemia: a Dose Response StudyStatus unknownNCT01323608Phase 4
- Study of Fludarabine Drug Exposure in Pediatric Bone Marrow TransplantationCompletedNCT01316549
- Beta-thalassemia and MicroparticlesCompletedNCT01284738Not applicable
- This Study Will Evaluate Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndromes (MDS), Thalassemia and Rare Anemia Types Having Transfusion-induced Iron Overload.CompletedNCT01250951Phase 4
- High-Tc Susceptometer to Monitor Transfusional Iron OverloadCompletedNCT01241357
- Traditional Chinese Medicine in the Supportive Management of Anaemic and Cytopenic (Leukopenia, Thrombocytopenia) Haematological DisordersCompletedNCT01224496Phase 1/2
- Evaluating the Safety and Effectiveness of Mozobil Mobilization in Adults With Beta-Thalassemia MajorCompletedNCT01206075Not applicable
- A Randomized Trial of LOVAZA in Pediatric Sickle Cell Disease (SCD)Status unknownNCT01202812Phase 2
- GDF 15 in Sickle Cell Disease and Hereditary SpherocytosisStatus unknownNCT01201135
- Genes Influencing Iron Overload StateCompletedNCT01158794
- Efficacy and Safety of Neridronate (Nerixia®)to Treat Osteoporosis in Patients With TM and TICompletedNCT01140321Phase 2
- Perceptions of Thalassemia Major in Singapore: An Exploratory Study of StigmaCompletedNCT01129076
- Amlodipine Use in the Prevention and Treatment of Iron Overload in Patients With Thalassemia MajorCompletedNCT01125254Phase 2/3
- Multi-Center Study of Iron Overload: Pilot StudyCompletedNCT01114776
- Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-ThalassemiaStatus unknownNCT01092169
- CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor TransplantCompletedNCT01049854Phase 2
- Safety and Pharmacokinetic Study of Escalating Multiple Doses of an Iron Chelator in Patients With Iron OverloadCompletedNCT01039636Phase 1
- Zoledronic Acid for the Prevention of Bone Loss Post-bone Marrow Transplantation for Thalassemia Major PatientsStatus unknownNCT01016093Phase 2/3
- Therapeutic Effects of Silymarin in Patients With B-thalassemia MajorStatus unknownNCT00999349Phase 2/3
- Iron Overload and Growth Velocity in Thalassemia and Sickle Cell AnemiaCompletedNCT00972231
- Demographic, Clinical and Laboratory Characteristics of Children With Alpha Thalassemia in Northern IsraelCompletedNCT00971984
- Blood Transfusions in Thalassemia Patients, Complications and Adverse EffectsCompletedNCT00971880
- The Spleen in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00971698
- Effect of Deferasirox on Patients With Cardiac MRI T2* < 20 MsecCompletedNCT00879242Phase 2
- Use of 3D/4D Ultrasound in the Evaluation of Fetal AnomaliesCompletedNCT00826917
- Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia IntermediaCompletedNCT00809042Phase 2
- Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia MajorCompletedNCT00800761Phase 4
- Phase 1/2 Study of HQK-1001 in Patients With Beta ThalassemiaCompletedNCT00790127Phase 1/2
- The Change of Coagulation Markers in Children With β-thalassemia Disease After Stem Cell TransplantationCompletedNCT00789516
- Iron Balance Study of Deferasirox, Deferoxamine and the Combination of BothStatus unknownNCT00738413Phase 1/2
- Clinical and Laboratory Characteristics of Sickle Cell Anemia Patients Admitted With FeverCompletedNCT00736060
- Clinical Diagnosis of Teenagers Admitted to Pediatric DepartmentsCompletedNCT00735540
- Sickle Cell Anemia Screening and Prevention in Northern IsraelCompletedNCT00735488
- Efficacy Study of the Use of Sequential DFP-DFO Versus DFPCompletedNCT00733811Phase 4
- Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood CellsCompletedNCT00730314Phase 1/2
- Oral Nifedipine to Treat Iron OverloadCompletedNCT00712738Phase 1
- Pegasys® Plus Ribavirin in Thalassemic Patients With Hepatitis C Virus InfectionCompletedNCT00707850Phase 4
- Bone Marrow for Hemoglobinopathy ResearchCompletedNCT00669305
- Evaluating People With Thalassemia: The Thalassemia Longitudinal Cohort (TLC) StudyCompletedNCT00661804
- Evaluating the Efficacy of Deferasirox in Transfusion Dependent Chronic Anaemias (Myelodysplastic Syndrome, Beta-thalassaemia Patients) With Chronic Iron OverloadCompletedNCT00564941Phase 4
- Phase I Study to Examine the Effect of Deferasirox on Renal Hemodynamics in β-thalassemia Patients With Transfusional Iron OverloadCompletedNCT00560820Phase 1
- T2* in Transfusion Dependant Anemia, MI, LVF, Normal PatientsCompletedNCT00520559
- Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512564
- Iron Overload Assesment in Sickle Cell Anemia and Sickle Cell ThalassemiaCompletedNCT00512226Not applicable
- Evaluating the Safety of Two Medications to Treat Hepatitis C in People With Thalassemia (The HepC Study)CompletedNCT00502788Phase 2
- Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic CounterStatus unknownNCT00481221
- Long Term Follow up in Sickle Cell Patients Treated by HydroxyureaCompletedNCT00480974
- Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia MajorCompletedNCT00480506
- Endocrine and Nutritional Assessment in B Thalassemia MajorCompletedNCT00456690Not applicable
- Invasive Infections in Children With HemoglobinopathiesCompletedNCT00456443
- Stem Cell Transplant in Sickle Cell Disease and ThalassemiaActive, not recruitingNCT00408447Phase 2
- Evaluation of Efficacy of Zoledronic Acid in Patients With Haemoglobin Syndromes (Thalassemia and Sicle Cell Anaemia) and Risk of Skeletal EventsCompletedNCT00346242Phase 4
- Evaluating the Safety of G-CSF Mobilization in Individuals With Beta Thalassemia MajorCompletedNCT00336362Not applicable
- Factors Promoting Increased Rate and Success of Pregnancy in the Thalassemia Population in TorontoStatus unknownNCT00327639
- Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart DiseaseApproved for marketingNCT00293098
- A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional HemosiderosisCompletedNCT00171171Phase 3